6365 results for "11+1双色球多少钱一注"

in 9.52 milliseconds.

• LP2100082-DNA_E02

  LP2100082-DNA_E02

  Dataset EGAD00001009914

• LP2100082-DNA_E03

  LP2100082-DNA_E03

  Dataset EGAD00001009915

• LP2100082-DNA_E04

  LP2100082-DNA_E04

  Dataset EGAD00001009916

• LP2100082-DNA_E05

  LP2100082-DNA_E05

  Dataset EGAD00001009917

• LP2100082-DNA_E06

  LP2100082-DNA_E06

  Dataset EGAD00001009918

• LP2100082-DNA_F01

  LP2100082-DNA_F01

  Dataset EGAD00001009919

• LP2100082-DNA_F03

  LP2100082-DNA_F03

  Dataset EGAD00001009921

• LP2100082-DNA_H03

  LP2100082-DNA_H03

  Dataset EGAD00001009930

• LP2100082-DNA_H04

  LP2100082-DNA_H04

  Dataset EGAD00001009931

• LP2100082-DNA_H05

  LP2100082-DNA_H05

  Dataset EGAD00001009932

• LP2100098-DNA_A01

  LP2100098-DNA_A01

  Dataset EGAD00001009933

• LP2100098-DNA_A03

  LP2100098-DNA_A03

  Dataset EGAD00001009934

• LP2100098-DNA_A05

  LP2100098-DNA_A05

  Dataset EGAD00001009935

• LP2100098-DNA_A07

  LP2100098-DNA_A07

  Dataset EGAD00001009936

• LP2100098-DNA_A09

  LP2100098-DNA_A09

  Dataset EGAD00001009937

• LP2100098-DNA_B03

  LP2100098-DNA_B03

  Dataset EGAD00001009939

• LP2100098-DNA_B01

  LP2100098-DNA_B01

  Dataset EGAD00001009938

• LP2100098-DNA_B05

  LP2100098-DNA_B05

  Dataset EGAD00001009940

• LP2100098-DNA_B07

  LP2100098-DNA_B07

  Dataset EGAD00001009941

• LP2100098-DNA_B09

  LP2100098-DNA_B09

  Dataset EGAD00001009942

• LP2100098-DNA_C01

  LP2100098-DNA_C01

  Dataset EGAD00001009943

• Genetic Basis of Cryptorchidism

  Non-syndromic cryptorchidism is a common malformation, but the genetic loci that increase susceptibility to cryptorchidism remain unknown. A genome-wide association study (GWAS) was completed to determine whether common allelic variants are associated with susceptibility to cryptorchidism. Two sets of discovery groups were genotyped. Group 1 (559 cases and 1772 controls) was genotyped with HumanHap550v1.0, HumanHap550v3.0 or Human610-quad v1.0. Group 2 (353 cases and 1149 controls) was genotyped with HumanOmniExpress-12v1 or HumanOmniExpress-12v1-1. The sample and marker QCs were performed separately using PLINK (v1.07; http://pngu.mgh.harvard.edu/purcell/plink/) and logistic regression analyses were performed with first and second multidimensional scaling (MDS) components as covariates.

  Study phs000986

• Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients

  OpACIN is a feasibility study including 20 patients with palpable stage III melanoma that were 1:1 randomized to receive ipilimumab 3mg/kg and nivolumab 1mg/kg, either 4 courses after surgery (adjuvant arm), or 2 courses prior to surgery and 2 courses post-surgery (neoadjuvant arm). WES and RNA-seq was performed on baseline biopsy material and correlated with outcome of the patients (relapse free survival). TCRseq from baseline tumor samples was used to analyse the top 100 tumor resident clones and analyse their change in PBMC comparing baseline versus week 6 of immunotherapy.

  Study EGAS00001003099

• Lifelines NEXT

  The Lifelines-NEXT is a cohort of newborns followed up from birth up to the age of 1 year and later. The cohort includes approximately 1,500 newborns and their mothers from the 3 provinces of the Northern Netherlands.

  Study EGAS50000000133

• Human Autism Genetics

  The goal of this study is to bring together the power of 1) whole exome sequencing, 2) homozygosity mapping in consanguineous families, and 3) transcriptional analysis in brain tissue to identify genetic causes of autism spectrum disorders (ASD).

  Study phs000639